Fidelity Investments’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Fidelity Investments’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-197,083	Closed	-$2.73M	–	2893
2014 Q4	$2.73M	Hold	197,083	–	–	﹤0.01%	2372
2014 Q3	$2.44M	Hold	197,083	–	–	﹤0.01%	2382
2014 Q2	$3.6M	Sell	197,083 -12,713	-6%	-$218K	﹤0.01%	2303
2014 Q1	$4.55M	Sell	209,796 -218,543	-51%	-$6.33M	﹤0.01%	2230
2013 Q4	$15.1M	Sell	428,339 -38,513	-8%	-$1.29M	﹤0.01%	1819
2013 Q3	$16.9M	Buy	466,852 +178,373	+62%	+$8.12M	﹤0.01%	1758
2013 Q2	$12.2M	Buy	+288,479	New	+$13.1M	﹤0.01%	1874

Other funds holding KBIO

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Fidelity Investments's KBIO Position: Q1 2015 in Review

Fidelity Investments sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 197,083 shares — an estimated $2.73M sold.

Fidelity Investments first reported a position in KBIO in Q2 2013 and held it in 7 quarters. The position peaked at $16.9M in Q3 2013. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

Fidelity Investments reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
Fidelity Investments sold 197,083 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $2.73M.
Fidelity Investments first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 7 quarters.
Fidelity Investments's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $16.9M in Q3 2013.
24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Fidelity Investments's 13F filing for Q1 2015, filed 14 May 2015.